Stock Earnings

Question 1

What are Astellas Pharma Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Astellas Pharma Inc has a total asset of $3,339,544, Net profit of $50,747

Question 2

What are the key financial ratios for ALPMF?

Accepted Answer

Astellas Pharma Inc's Current ratio is 1.82, has a Net margin is 2.65, sales per share of $1,064.08.

Question 3

How is Astellas Pharma Inc's revenue broken down by segment or geography?

Accepted Answer

Astellas Pharma Inc largest revenue segment is Pharmaceutical, at a revenue of 1,912,323,000,000 in the most earnings release.For geography, United States is the primary market for Astellas Pharma Inc, at a revenue of 866,378,000,000.

Question 4

Is Astellas Pharma Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Astellas Pharma Inc has a net profit of $50,747

Question 5

Does Astellas Pharma Inc have any liabilities?

Accepted Answer

yes, Astellas Pharma Inc has liability of 1,826,289

Question 6

How many outstanding shares for Astellas Pharma Inc?

Accepted Answer

Astellas Pharma Inc has a total outstanding shares of 1,790.31

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	2,006,816	1,912,323	1,603,672	1,518,619	1,296,163	1,249,528
Revenue Growth (YoY)	13%	19%	6%	17%	4%	-4%
Cost of Revenue	375,740	349,206	292,485	288,353	253,009	246,063
Gross Profit	1,631,076	1,563,117	1,311,187	1,230,266	1,043,154	1,003,465
Selling, General & Admin	840,455	843,032	773,544	630,272	548,840	504,316
Research & Development	298,610	327,651	294,187	276,128	246,010	224,489
Operating Expenses	1,485,231	1,299,576	1,186,580	998,614	825,009	752,533
Other Non Operating Income (Expenses)	--	-219	-1,724	2,304	-2,430	73
Pretax Income	136,801	31,237	24,969	132,361	156,886	145,324
Income Tax Expense	11,930	-19,510	7,924	33,647	32,800	24,734
Net Income	124,871	50,747	17,045	98,714	124,086	120,589
Net Income Growth	128%	198%	-83%	-20%	3%	-38%
Shares Outstanding (Diluted)	1,791.2	1,797.15	1,799.66	1,825.06	1,850.6	1,857.12
Shares Change (YoY)	0%	0%	-1%	-1%	0%	-1%
EPS (Diluted)	69.71	28.23	9.47	54.08	67.05	64.93
EPS Growth	129%	198%	-82%	-19%	3%	-38%
Free Cash Flow	334,585	137,181	89,979	239,226	180,995	229,402
Free Cash Flow Per Share	186.79	76.33	49.99	131.07	97.8	123.52
Gross Margin	81.27%	81.73%	81.76%	81.01%	80.48%	80.3%
Operating Margin	7.26%	13.78%	7.77%	15.25%	16.83%	20.08%
Profit Margin	6.22%	2.65%	1.06%	6.5%	9.57%	9.65%
Free Cash Flow Margin	16.67%	7.17%	5.61%	15.75%	13.96%	18.35%
EBITDA	339,790	400,303	223,427	270,088	246,428	274,695
EBITDA Margin	16.93%	20.93%	13.93%	17.78%	19.01%	21.98%
D&A For EBITDA	193,945	136,762	98,820	38,436	28,283	23,763
EBIT	145,845	263,541	124,607	231,652	218,145	250,932
EBIT Margin	7.26%	13.78%	7.77%	15.25%	16.83%	20.08%
Effective Tax Rate	8.72%	-62.45%	31.73%	25.42%	20.9%	17.01%

Astellas Pharma Inc (ALPMF) Price

ALPMF Stock Price Chart

ALPMF Income

Follow-Up Questions